Phase 3 Study Investigating Ibrutinib In Older CLL Patients

Phase 3 Study Investigating Ibrutinib In Older CLL Patients

User Photo
obr

1 year
80 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses Phase 3 Study Investigating Ibrutinib In Older CLL Patients. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Up Next Autoplay
>